China SXT Pharmaceuticals (SXTC) Prepaid Assets (2018 - 2025)
China SXT Pharmaceuticals (SXTC) recorded quarterly Prepaid Assets of $319058.0 in Q1 2025, up 43.07% quarter-over-quarter from $223007.0 in Q3 2024, and up 908.59% on a YoY basis from $31634.0 in Q1 2024.
China SXT Pharmaceuticals (SXTC) Prepaid Assets (2018 - 2025) Analysis & Trends
China SXT Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $319058.0 for Q1 2025.
- In Q1 2025, Prepaid Assets rose 908.59% year-over-year to $319058.0; the TTM figure through Mar 2025 stood at $319058.0 (up 908.59% YoY), while the FY2025 annual figure was $319058.0, up 908.59% from the prior year.
- Prepaid Assets was $319058.0 for Q1 2025 at China SXT Pharmaceuticals, up from $223007.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.9 million in Q1 2021 to a low of $31634.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $724756.2 across 5 years, with a median of $319058.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 86.73% in 2023, then surged 908.59% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $1.8 million in 2021, then sank by 42.75% to $1.0 million in 2022, then plunged by 86.73% to $137978.0 in 2023, then jumped by 61.63% to $223007.0 in 2024, then soared by 43.07% to $319058.0 in 2025.
- The last three Prepaid Assets figures came in at $319058.0 (Q1 2025), $223007.0 (Q3 2024), and $31634.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | China SXT Pharmaceuticals | 187.96 Mn | 166.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 319,058.00 |
| Sep 30, 2024 | 223,007.00 |
| Mar 31, 2024 | 31,634.00 |
| Sep 30, 2023 | 137,978.00 |
| Mar 31, 2023 | 230,642.00 |
| Sep 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 864,709.00 |
| Sep 30, 2021 | 1.82 Mn |
| Mar 31, 2021 | 1.86 Mn |
| Sep 30, 2020 | 2.17 Mn |
| Mar 31, 2020 | 4.62 Mn |
| Mar 31, 2019 | 707,337.00 |
| Mar 31, 2018 | 910,606.00 |